Biosensing systems for measurement of lactose

US10024797B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10024797-B2
Application numberUS-201113988723-A
CountryUS
Kind codeB2
Filing dateNov 22, 2011
Priority dateNov 22, 2010
Publication dateJul 17, 2018
Grant dateJul 17, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Herein disclosed are biosensing systems that measure lactose concentration in a solution.

First claim

Opening claim text (preview).

What is claimed: 1. A biosensing system that measures lactose concentration in a solution, said biosensing system comprising: an optode comprising an optical fiber having a first tip and a second tip, a luminescent transducer layer covering said first tip, a biocomponent layer covering said luminescent transducer layer, said biocomponent layer comprising at least one biocomponent that catalyzes a reaction with lactose in said solution, wherein said at least one biocomponent is immobilized within said biocomponent layer using a hydrogel or polymer matrix, a porous membrane covering said biocomponent layer, wherein said porous membrane provides a mass transfer resistance between said biocomponent layer and said solution, a photon-detection device coupled to said second tip, wherein the photon-detection device is configured to detect photons emitted from the luminescent transducer layer through the optical fiber, and a signal processing system coupled to said photon-detection device. 2. The biosensing system of claim 1 whereby said lactose concentration in said solution, the depth of said biocomponent layer, the depth of said porous membrane, the diffusion coefficient of lactose in said porous membrane, and the K M and V max of said catalytic reaction between said biocomponent and lactose are selected such that Da is greater than the value of 1−β and the quotient between Da 2 and 4β is from about 10 to at least 1000, wherein V max is the maximum reaction rate of said biocomponent with lactose under saturating lactose concentrations, and wherein K M is the lactose concentration at which the reaction rate of said biocomponent and lactose is half of V max , and wherein β is the lactose concentration in said solution divided by said K M of said biocomponent for lactose, and wherein Da is a dimensionless Damköhler number, and wherein Da is (h e V max h p )/(D p K M ), and wherein h e is the thickness of said biocomponent layer, and wherein h p is the thickness of said porous membrane, and wherein D p is the diffusion coefficient of lactose in said porous membrane. 3. The biosensing system of claim 1 wherein said luminescent transducer layer contains a luminescent agent that is selected from the group consisting of a fluorescent agent, a phosphorescent agent, a bioluminescent agent, or a chemiluminescent agent. 4. The biosensing system of claim 1 wherein said luminescent transducer layer contains a luminescent agent that is selected from the group consisting of: trisodium 8-hydroxy-1,3,6-trisulphonate, fluoro (8-anilino-l-naphthalene sulphonate), tris(bipyridine)ruthenium(II) complex, Tris(4,7-diphenyl-1,10-phenanthroline)Ru(II) (RuDPP), ruthenium complexes, and acridinium- and quinidinium-based reagents, fluorescein, fluoresceinamine, or a fluorescein containing compound. 5. The biosensing system of claim 1 wherein said biocomponent layer comprises a biocomponent selected from the group consisting of at least one enzyme from Enzyme Commission numbers 1.1.3, 1.2.3, 1.3.3, 1.4.3, 1.5.3, 1.6.3, 1.7.3, 1.8.3, 1.9.3, 1.10.3, 1.16.3, 1.17.3, 1.21.3, and 3.2.1.23. 6. The biosensing system of claim 1 wherein said polymer matrix comprises one or more of polyacrylamide, polystyrene, polymethacrylate, polyvinylalcohol and polyurethane, and wherein said biocomponent is entrapped within said polymer matrix. 7. The biosensing system of claim 6 wherein said biocomponent is bound to said matrix layer through adding crosslinking agents to said biocomponent entrapped within said matrix layer, and wherein said crosslinking agents are selected from the group consisting of glutaraldehyde, hexamethylene diisocyanate and 1,5-dinitro-2,4-difluorobenzene, polyethyleneimine, hexamethylenediamine and formaldehyde. 8. The biosensing system of claim 1 wherein said luminescent transducer layer is bound in a layer of molecules bound to the first tip of said optical fiber, said layer of molecules is selected from the group consisting of cellulose, cellulose derivatives, silica, glass, dextran, starch, agarose, porous silica, chitin and chitosan. 9. The biosensing system of claim 1 , said porous membrane is polycarbonate having a pore size of from about 0.005 μm to about 0.025 μm. 10. The biosensing system of claim 9 , said porous membrane comprises a coating of polyurethane. 11. The biosensing system of claim 1 wherein said biocomponent comprises beta-galactosidase and glucose oxidase and wherein luminescence of said luminescent transducer layer is at least partially quenched with oxygen. 12. The biosensing system of claim 11 wherein said biocomponent further comprises catalase. 13. The biosensing system of claim 1 wherein said biocomponent comprises beta-galactosidase and galactose oxidase and wherein luminescence of said luminescent transducer layer is at least partially quenched with oxygen. 14. The biosensing system of claim 13 wherein said biocomponent further comprises catalase. 15. The biosensing system of claim 1 wherein said biocomponent is carbohydrate oxidase and wherein luminescence of said luminescent transducer layer is at least partially quenched with oxygen. 16. The biosensing system of claim 1 wherein said biocomponent further comprises catalase. 17. The biosensing system of claim 1 wherein said biocomponent is cellobiose dehydrogenase and wherein luminescence of said luminescent transducer layer interacts with protons. 18. The biosensing system of claim 1 wherein said biocomponent comprises beta-galactosidase and hexose oxidase and wherein luminescence of said luminescent transducer layer is at least partially quenched with oxygen. 19. The biosensing system of claim 18 wherein said biocomponent further comprises catalase. 20. The biosensing system of claim 1 , wherein said hydrogel comprises one or more of algal polysaccharides, agarose, alginate, gelatin, collagen, pectin, poly(carbamoyl)sulfonate, locust bean gum, and gellan, and wherein said biocomponent is entrapped within said hydrogel. 21. The biosensing system of claim 1 , wherein said biocomponent layer further comprises one or more of a gel-hardening agent and a stabilizing agent. 22. The biosensing system of claim 21 , wherein said one or more of a gel-hardening agent and a stabilizing agent comprises one or more of glutaraldehyde, polyethyleneimine, hexamethylenediamine and formaldehyde. 23. The biosensing system of claim 1 , wherein said porous membrane enables said biosensing system to measure lactose in said solution at concentrations up to and including 20 mM. 24. The biosensing system of claim 1 , wherein said porous membrane enables said biosensing system to measure lactose in said solution at concentrations up to and including 100 mM. 25. The biosensing system of claim 1 , wherein said luminescent transducer layer comprises one or more fluorophores capable of interacting with protons.

Assignees

Inventors

Classifications

  • Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence) · CPC title

  • Tip coated light guide · CPC title

  • Fluorescence · CPC title

  • Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53) · CPC title

  • Indicator and selective membrane · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10024797B2 cover?
Herein disclosed are biosensing systems that measure lactose concentration in a solution.
Who is the assignee on this patent?
Reardon Kenneth F, Dandy David S, Holcomb Ryan E, and 1 more
What technology area does this patent fall under?
Primary CPC classification G01N21/6486. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).